Keystone eSymposia Logo

Global Priorities in Vaginal Health: Microbes, Mucosal Immunity and Interventions

November 10-12, 2021
*Program is in development and subject to change


The live portion of this conference has concluded and all presentations are now available for purchase on demand. Registrants to the live event may access this content anytime for up to 3 months following the event.

 Free Access to On Demand Content to Scientists from Low-and Middle-Income Countries

Keystone Symposia welcomes the global scientific community and aims to connect researchers within and across disciplines to accelerate the advancement of biomedical and life sciences. This form may be used for scientists from low- and middle-income countries of all career stages to determine eligibility and request free access to scientific content presented during recent eSymposia events. If eligible, you will be sent an access code for the On Demand content of the eSymposia event(s) of interest. Application must be completed by February 1, 2022.

Apply Here

The female genital tract environment represents an intricate interplay between commensal microbes, pathogens, small molecule metabolites and host immune cells resulting in health and disease consequences for women, their sexual partners, and neonates. Refined characterization of the genital tract using sophisticated methods has expanded our understanding of mucosal immunology, the microbiome, the metabolome, and the proteome. Mechanisms leading to adverse outcomes, particularly elevated risk of HIV acquisition, are being unraveled, and an increasing number of interventions are in clinical trials. In this meeting, we will examine cutting-edge knowledge needed to tackle some of the most challenging global problems in reproductive and sexual health, including current understanding of female genital tract microbiology and immunology, and advances in therapeutics and preventatives intended to modify or protect these environments. Potential mechanisms leading to adverse outcomes, and prospective prevention and/or treatment interventions will be presented and discussed. Pathways for development of novel interventions, including industry partnership and regulatory strategies will be considered. The progress made in recent years at the bench and in clinical trials should inform global health interventions aimed at sustaining sexual and reproductive health for women especially in resource-limited settings, where women suffer the most severe consequences of these challenges.

Apply Here for Free On Demand Access


Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD


Abstract Submission
‣ For Short Talk Consideration: Passed
‣ For ePoster Presentation: Passed
Final ePoster / SciTalk Submission: Passed
Financial Aid Application: Passed

*Abstract submission is required in order to submit an ePoster and/or Scitalk


Program Details

Program details will be available soon.

Keynote Speaker

[Pedro L. Alonso, MD, PhD]

[Pedro L. Alonso, MD, PhD]
[World Health Organization, Director of the Global Malaria Programme]

Speaking at this eSymposia

Kingsley C. Anukam

Nnamdi Azikiwe University, Nigeria

Eric Armstrong

University of Toronto, Canada

Emily P. Balskus

Harvard University, USA

Yasmine Belkaid

NIAID, National Institutes of Health, USA

Robert D. Burk

Albert Einstein College of Medicine, USA

Craig R. Cohen

University of California, San Francisco, USA

Bhabatosh Dos

Translational Health Science and Technology Institute, India

David N. Fredricks

Fred Hutchinson Cancer Research Center, USA

Betsy Herold

Albert Einstein College of Medicine, USA

Susan P. Holmes

Stanford University, USA

Heather B. Jaspan

Seattle Children's Research Institute / University of Cape Town, USA

Douglas S. Kwon

Harvard Medical School, USA

Jordan K. Kyongo

East Africa Research & Innovation Hub, Kenya

Lenine Liebenberg

CAPRISA, South Africa

Jeanne M. Marrazzo

University of Alabama at Birmingham, USA

Lindi Masson

Burnet Institute, Australia

Lyle McKinnon

University of Manitoba, Canada

Caroline M. Mitchell

Massachusetts General Hospital, USA

Sinaye Ngcapu

CAPRISA, South Africa

Jo-Ann S. Passmore

University of Cape Town, South Africa

Sujatha Srinivasan

Fred Hutchinson Cancer Research Center, USA

Jill Steinbach-Rankins

University of Louisville, USA

Janneke van de Wijgert

University Medical Center Utrecht, Netherlands





Additional Support




Funding for this conference was made possible (in part) by Grant No. [GRANT NUMBER - UPDATE] from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Media-in-Kind Support










The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.


This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community.  Here, Debbie Johnson, our CEO, explains how we're going to do that.

Donate to Keystone Symposia

Donate to Keystone Symposia